OSR Health, Inc.
corporate_fare Company Profile
OSR Health, Inc. (OTC:OSRH) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 30 items for OSRH at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-13, rated 8/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 13 rated 8 or above. Recent SEC coverage for OSRH spans 8-K, 10-Q, PRE 14A, DEFA14A.
Recent high-impact activity:
- Auditor Resigns at Micro-Cap OSR Health, Citing Unpaid 2025 Audit Fees
- OSR Health Exercises $15M Equity Option, Swaps Cash Purchase for Staged Convertible Notes
- OSR Health Appeals Nasdaq Delisting, Trading Suspension Still Set for Aug 26
- OSR Health Faces Nasdaq Delisting; Trading Suspension Set for August 26
- OSR Health's Q2 Loss, Unremediated Material Weaknesses, and Shrinking Cash
Short Interest & Short Volume
1.47 days to coverFINRA reported short interest of 693,496 shares in OSRH as of the October 30, 2026 settlement, a 23.3% decrease from the prior period — about 1.5 days to cover at its recent average daily volume. On November 20, 2026, 20.0% of OSRH volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Dilution Risk
Low riskFiling-implied dilution signals for OSRH, detected from its recent SEC filings · based on capital-structure filings through 2026-05-26.
Omnibus Incentive Plan Expansion · Significant Potential Dilution
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →